BridgeBio Pharma Inc
(NAS:BBIO)
$
29.08
-0.37 (-1.26%)
Market Cap: 5.50 Bil
Enterprise Value: 6.97 Bil
PE Ratio: 0
PB Ratio: 0
GF Score: 41/100 BridgeBio Pharma Inc at Cowen Health Care Conference Transcript
Mar 08, 2023 / 03:30PM GMT
Release Date Price:
$16.4
(-11.59%)
Tyler Van Buren
Cowen Group - Analyst
(audio in progress) Tyler Van Buren here, senior biotech analyst at TD Cowen. Thanks again for being here on the third day of the TD Cowen 43rd Annual Healthcare Conference. For the next session, I'm very excited to have a fireside chat with BridgeBio. And from BridgeBio, we have Neil Kumar, the Co-Founder and CEO.
Neil, thank you very much for joining me.
Neil Kumar
BridgeBio Pharma, Inc. - Founder, CEO, Director
Thanks so much for having me. Appreciate the time.
Questions & Answers
Tyler Van Buren
Cowen Group - Analyst
So before we get started, if you guys have questions, feel free to raise your hand and we'll try to get them answered. But let's go ahead and get into it with a achondroplasia. You guys clearly shocked the Street on Monday. So I'm just curious to hear when did you get the data and what was your initial reaction?
Neil Kumar
BridgeBio Pharma, Inc. - Founder, CEO, Director
Well, we got the data
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot